CMS certification 310051
Overlook Medical Center
99 Beauvoir Avenue, Summit, NJ 07901
Overlook Medical Center has a CMS overall rating of 5 out of 5 stars. 71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. Emergency patients spend a median of 3 h 12 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 2,876 completed surveys, 25% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NJ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 391 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 12 min | 3 h 6 min | 2 h 42 min |
| Left before being seen Lower is better · 108,737 patients | 1% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 153 patients | 60% | 73% | 65% |
How Overlook Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Overlook Medical CenterThis hospital | 5/5 | 71% | 3 h 12 min | 7 better 2 worse |
| Trinitas Regional Medical CenterSame county · Elizabeth | 3/5 | 63% | 3 h 29 min | 1 better 2 worse |
| Robert Wood Johnson University Hospital at RahwaySame county · Rahway | 4/5 | 65% | 1 h 54 min | 1 better 2 worse |
| Morristown Medical CenterSame ZIP area · Morristown | 5/5 | 80% | 4 h 10 min | 14 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Summit.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,749 cases | Too few cases | 2.4% | 3.9% |
| Heart attack 216 cases | Too few cases | 10.1% | 11.9% |
| Heart failure 727 cases | Too few cases | 10.2% | 11.1% |
| Pneumonia 970 cases | Too few cases | 14.1% | 15.2% |
| Stroke 599 cases | Too few cases | 8.3% | 11.9% |
| COPD 181 cases | Too few cases | 6.1% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Better | 0.73 likely 0.47 – 0.99 | 1 |
| After hip or knee replacement 143 cases | Too few cases | 3.9% | 4.1% |
| Deaths after a serious but treatable surgical complication 128 cases | No different | 151.58 per 1,000 likely 109.98 per 1,000 – 193.17 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 9,827 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.68 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 10,788 cases | No different | 0.25 per 1,000 likely 0.06 per 1,000 – 0.43 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 10,985 cases | No different | 0.3 per 1,000 likely 0.12 per 1,000 – 0.47 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,128 cases | No different | 2.3 per 1,000 likely 0.92 per 1,000 – 3.67 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,012 cases | No different | 1.32 per 1,000 likely 0 per 1,000 – 2.85 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 999 cases | No different | 5.93 per 1,000 likely 0.15 per 1,000 – 11.71 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,306 cases | No different | 3.56 per 1,000 likely 1.81 per 1,000 – 5.3 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 946 cases | No different | 4.23 per 1,000 likely 1.1 per 1,000 – 7.36 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 575 cases | No different | 1.79 per 1,000 likely 0.38 per 1,000 – 3.2 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,294 cases | No different | 0.84 per 1,000 likely 0.06 per 1,000 – 1.62 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.61 likely 0.22 – 1.35 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.18 likely 0.03 – 0.59 | 1 |
| Surgical site infections after colon surgery | No different | 0.49 likely 0.18 – 1.08 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.96 likely 0.16 – 3.17 | 1 |
| MRSA bloodstream infections | No different | 0.47 likely 0.12 – 1.27 | 1 |
| C. diff intestinal infections | Better | 0.46 likely 0.3 – 0.66 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 232 cases | Too few cases | 14% | 14.4% |
| Readmitted after heart failure 941 cases | Too few cases | 19.9% | 21.3% |
| Readmitted after pneumonia 1,138 cases | Too few cases | 16.3% | 17.3% |
| Readmitted after COPD 259 cases | Too few cases | 21.5% | 20% |
| Readmitted after hip or knee replacement 147 cases | Too few cases | 5.4% | 5.8% |
| Days back in hospital after a heart attack 186 cases | Too few cases | -8.8 days per 100 | — |
| Days back in hospital after heart failure 771 cases | Too few cases | -21.4 days per 100 | — |
| Days back in hospital after pneumonia 952 cases | Too few cases | -2.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,579 cases | No different | 13.1 per 1,000 likely 10.2 per 1,000 – 16.6 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 300 cases | No different | 12.8 per 100 likely 9.9 per 100 – 16.2 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 300 cases | No different | 4.3 per 100 likely 3 per 100 – 6.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,033 cases | No different | 0.8 likely 0.7 – 1 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
341 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 117 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 36 |
| Nurse Anesthetist, Certified Registered | 22 |
| Nurse Practitioner | 20 |
| Emergency Medicine | 19 |
| Anesthesiology | 18 |
| Clinical | 17 |
| Hospitalist | 16 |
| Diagnostic Radiology | 14 |
| Neurology | 12 |
| Physician Assistant | 12 |
| Family Medicine | 10 |
| Acute Care | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $399,592
- 2020 $450,412
- 2021 $738,920
- 2022 $396,436
- 2023 $230,590
- 2024 $122,420
- 2025 $418,605
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $109,091 | 3 |
| Gifts | $519 | 1 |
| Debt forgiveness | $490 | 5 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $149,478 | 8 |
| Amgen Inc. | $142,681 | 4 |
| Hologic Sales and Service, LLC | $109,091 | 3 |
| E.R. Squibb & Sons, L.L.C. | $6,288 | 1 |
| Exelixis Inc. | $6,147 | 1 |
| Sanofi US Services INC. | $3,445 | 3 |
| Bioventus LLC | $906 | 4 |
| Merck Sharp & Dohme LLC | $467 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants Wi… Amgen Inc. | $119,885 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Back… Novartis Pharmaceuticals Corporation | $80,822 |
| A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular… Novartis Pharmaceuticals Corporation | $38,507 |
| A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the prog… Novartis Pharmaceuticals Corporation | $29,618 |
| A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa Indu… Amgen Inc. | $18,003 |
| A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjgren's Syndrome (POETYK SjS-1) E.R. Squibb & Sons, L.L.C. | $6,288 |
| A Phase 3, Randomized, Double-blinded, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Radioiodine Refractory Defferentiated Thy… Exelixis Inc. | $6,147 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cance… Amgen Inc. | $3,593 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Overlook Medical Center
Is Overlook Medical Center a good hospital?
Overlook Medical Center has a CMS overall rating of 5 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Overlook Medical Center?
71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 2,876 completed HCAHPS surveys.
How long is the wait in the Overlook Medical Center emergency room?
Emergency patients spend a median of 3 h 12 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Overlook Medical Center receive money from drug and device companies?
Drug and device makers reported $418,605 in payments to Overlook Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.